Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity

Figure 3

Correlation between serum sIL-2R levels and DM disease activity; (a) correlation between serum sIL-2R levels and physician VAS; (b) correlation between serum sIL-2R levels and MYOACT scores; (c) correlation between serum sIL-2R levels and MMT8; (d) serum sIL-2R levels before and after treatment; (e) MYOACT scores before and after treatment; (f) physician VAS before and after treatment; (g) changes in sIL-2R levels correlated with changes in physician VAS; (h) changes in sIL-2R levels correlated with changes in MYOACT score.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)